BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

eTheRNA Manufacturing Announces New LNP Formulation Development and Production Service

This new LNP service uses eTheRNA’s proprietary lipid libraries and proprietary formulations to facilitate targeted delivery and tailored biodistribu...

March 29, 2022 | News

Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

March 28, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia

The MOH Malaysia recommends using Convidecia™ as a heterologous booster for individuals aged 18 and above who have been administered two doses of ina...

March 23, 2022 | News

Novavax and SII Announce First EUA of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorized&n...

March 23, 2022 | News

Progresses Made in Series of Studies of Prevention and Control of COVID-19 with Lianhua Qingwen Capsules

These experimental results show that Lianhua Qingwen Capsules have significant inhibiting effect on the cytopathic effect induced by Omicron variant so as ...

March 22, 2022 | News

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries

Biolexis will launch AKS-452 as “AmbiVax-CTM” for global markets where the cold chain elimination would contribute to improving immunization ...

March 21, 2022 | News

Novavax Announces Launch of Global Vaccine Education Programs

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

March 11, 2022 | News

Nippon Express USA Acquires GDP Certification for CFS

Inclusive of temporary storage, at temperature-controlled facilities in its CFS near Los Angeles International Airport (effective November 2...

March 09, 2022 | News

Exclusive license for Croda to commercialise SSI’s CAF® vaccine adjuvants

Croda International Plc, which uses smart science to improve lives, announces today that it has entered a strategic collaboration with Statens Serum Instit...

March 04, 2022 | News

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

According to the State Council, for those aged 18 and above who have completed a 6-month vaccination schedule using inactivated COVID-19 vaccines, and thos...

February 21, 2022 | News

TGA Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)

"The TGA authorization for the use of our COVID-19 vaccine in children 6-11 years old in Australia is an important milestone for Moderna as it is the first...

February 18, 2022 | News

Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

February 15, 2022 | News

Kintor Pharma Announces First Patient Dosing in China

Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...

February 14, 2022 | News

mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN

New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine ...

February 08, 2022 | News

Stay Connected